CARE reaffirms A+ rating to IOL Chemicals and Pharmaceuticals
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Cipla has a robust governance model focused on sustainability
PEEK brings a new quality to dental care for patients
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
Rare childhood cancer subtype, Ph+ ALL, is found in 3-4% of pediatric cases and 25% of adult cases
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
The launch of HULIO in the United States is an important milestone for Biocon Biologics
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Subscribe To Our Newsletter & Stay Updated